Generic medications in ophthalmology.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23143788.
- Also identified by DOI 10.1136/bjophthalmol-2012-302245.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this review is to discuss the process of genericisation of medications in the US and Europe with a focus on ophthalmic drugs. Regulatory guidelines of the US Food and Drug Administration and the European Medicines Agency will be discussed, and the advantages and concerns of genericisation will be explored. We will look at various studies concerning the safety and efficacy of generic drugs compared to their branded counterparts. In particular, the challenges of assuring bioequivalence and therapeutic equivalence in topical ophthalmic drugs will be examined.
Medical subject headings
- Drugs, Generic
- Eye Diseases
- Ophthalmology